Am J Pathol

1. WANG Z, Sun X, Chen Z, Yu J, et al
   Nonalcoholic Steatohepatitis Exacerbates Inflammatory Bone Destruction and Macrophage NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Ligature-Induced Periodontitis.
   Am J Pathol. 2025 Nov 7:S0002-9440(25)00410-9. doi: 10.1016/j.ajpath.2025.
   

   >> Share

   
   
2. GASPARI C, Beaupere C, Richard S, Peixoto E, et al
   Loss of aquaporin-1 in tumor cells fosters intrahepatic cholangiocarcinoma progression.
   Am J Pathol. 2025 Nov 6:S0002-9440(25)00406-7. doi: 10.1016/j.ajpath.2025.
   

   >> Share

   
   

   
   BMC Cancer

3. LIU Y, Wu C, Huang Q, Zhou Y, et al
   Neoadjuvant chemotherapy followed by surgery versus upfront surgery for intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
   BMC Cancer. 2025;25:1757.
   

   >> Share

   
   
4. FAN Y, Yang R, Shu Y, Xie W, et al
   Preoperative prediction and localization of synchronous metastases in colon cancer: the role of CECT combined with clinical characteristics.
   BMC Cancer. 2025;25:1755.
   

   >> Share

   
   

   
   BMC Gastroenterol

5. ABOAGYE JO, Ayanful-Torgby R, Zhou L, Wormenor PP, et al
   Concordance of cancer-associated cytokines and mitochondrial DNA deletions in individuals with hepatocellular carcinoma and people living with HIV in Ghana.
   BMC Gastroenterol. 2025;25:799.
   

   >> Share

   
   
6. REDDY A, Elmasry M, Palacio C, Nguyen T, et al
   Computed tomography poorly detects gastroesophageal varices compared with endoscopy: a real-world single-center retrospective review.
   BMC Gastroenterol. 2025;25:800.
   

   >> Share

   
   
7. QIN L, Qiu ZC, Xie F, Zhang Y, et al
   Low preoperative serum creatinine levels are associated with poor prognosis in patients with hepatocellular carcinoma after liver resection: a multicenter study.
   BMC Gastroenterol. 2025;25:807.
   

   >> Share

   
   
8. YE D, Ma H, Zhou J, Wang J, et al
   Serum complement C3 as a diagnostic biomarker for metabolic dysfunction -associated steatotic liver disease in middle-aged and elderly adults: a cross-sectional study.
   BMC Gastroenterol. 2025;25:801.
   

   >> Share

   
   
9. HUANG Z, Zhou M, Feng S, Xiao X, et al
   Gamma-glutamyltransferase and the survival of hepatocellular carcinoma patients after transarterial chemoembolization: a meta?analysis and systematic review.
   BMC Gastroenterol. 2025;25:802.
   

   >> Share

   
   

   
   Dig Dis Sci

10. XUE Q, Peng F, Guo C, Zhou Y, et al
    S100A6 Regulated by PATZ1 Promotes Liver Fibrosis by Activating Hepatic Stellate Cells.
    Dig Dis Sci. 2025 Nov 13. doi: 10.1007/s10620-025-09533.
    

    >> Share

    
    
11. MA AT, Sola E
    Differentiating Hepatorenal Syndrome from Acute Tubular Necrosis in Patients with Decompensated Cirrhosis: Can Metabolomics or Proteomics Help?
    Dig Dis Sci. 2025 Nov 12. doi: 10.1007/s10620-025-09513.
    

    >> Share

    
    
12. CAO L, Huang Y, Zhao J, Qiu Y, et al
    Dihydroartemisinin: A Targeting Agent of CCT3-Mediated Oxidative Stress to Enhance the Antitumor Activity of Doxorubicin in Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Nov 8. doi: 10.1007/s10620-025-09503.
    

    >> Share

    
    
13. MA S, Alsabawi Y, Kanwal F, Duong H, et al
    The Association Between Physical Activity, Sedentary Time, and Sleep with Risk of Hepatocellular Carcinoma in Patients with Cirrhosis.
    Dig Dis Sci. 2025 Nov 7. doi: 10.1007/s10620-025-09527.
    

    >> Share

    
    

    
    Gut

14. CAO J, Qin S, Li B, Zhang Z, et al
    Extracellular vesicle-induced lipid dysregulation drives liver premetastatic niche formation in colorectal cancer.
    Gut. 2025 Jun 25:gutjnl-2025-334851. doi: 10.1136/gutjnl-2025-334851.
    

    >> Share

    
    

    
    Hepatology

15. BANSAL MB, Patton H, Morgan TR, Carr RM, et al
    Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance.
    Hepatology. 2025 Nov 7. doi: 10.1097/HEP.0000000000001608.
    

    >> Share

    
    
16. EL-KHOUEIRY AB, Kim RD, Harris WP, Sung MW, et al
    A multicenter dose-defining/expansion phase 1b study of first-line regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma.
    Hepatology. 2025 Nov 10. doi: 10.1097/HEP.0000000000001585.
    

    >> Share

    
    
17. ZHAO J, Hou L, Dery KJ, Yuan X, et al
    Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation.
    Hepatology. 2025 Nov 11. doi: 10.1097/HEP.0000000000001609.
    

    >> Share

    
    
18. MULIAWAN GK, Lee TKW
    Metabolic reprogramming in macrophages: A glutamine rescue in beta-catenin mutant hepatocellular carcinoma.
    Hepatology. 2025 Nov 13. doi: 10.1097/HEP.0000000000001619.
    

    >> Share

    
    
19. HUANG X, Zhu T, Li S, Liu T, et al
    Development and validation of a non-invasive score for at-risk metabolic dysfunction-associated steatohepatitis in individuals with obesity undergoing bariatric surgery.
    Hepatology. 2025 Nov 13. doi: 10.1097/HEP.0000000000001612.
    

    >> Share

    
    

    
    Indian J Gastroenterol

20. KOSUTA I, Kozina L, Cizmic P, Kosuta L, et al
    Response to "Toward better integrated hepatology care for women with substance use disorders".
    Indian J Gastroenterol. 2025 Nov 12. doi: 10.1007/s12664-025-01883.
    

    >> Share

    
    
21. SHARMA K, Ghosh A
    Toward better integrated hepatology care for women with substance use disorders.
    Indian J Gastroenterol. 2025 Nov 12. doi: 10.1007/s12664-025-01877.
    

    >> Share

    
    

    
    J Gastroenterol

22. ZHOU LX, He CH, Dong H, Gao TM, et al
    Validation of Baveno VII criteria for recompensation in patients with decompensated cirrhosis treated by laparoscopic splenectomy and azygoportal disconnection.
    J Gastroenterol. 2025 Nov 8. doi: 10.1007/s00535-025-02317.
    

    >> Share

    
    

    
    J Hepatol

23. FRANCIS H, Glaser S, Ueno Y, Lesage G, et al
    Corrigendum to 'cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway' (J Hepatol 41 [2004] 528-537).
    J Hepatol. 2025 Nov 7:S0168-8278(25)02563-2. doi: 10.1016/j.jhep.2025.
    

    >> Share

    
    

    
    PLoS Genet

24. YANG Z, Liang W, Zhang Q, Weng C, et al
    The role of hypothyroidism in cirrhosis pathogenesis: A retrospective cohort study and multi-omics integration analysis.
    PLoS Genet. 2025;21:e1011947.
    

    >> Share

    
    

    
    PLoS One

25. LACALAMITA A, Monaco A, Serino G, Marinazzo D, et al
    Unveiling complex patterns: An information-theoretic approach to high-order behaviors in microarray data.
    PLoS One. 2025;20:e0336379.
    

    >> Share

    
    
26. WU B, Zhang Z, Xu C, Zhao J, et al
    Aerobic exercise improved liver steatosis by modulating miR-34a-mediated PPARalpha/SIRT1-AMPK signaling pathway.
    PLoS One. 2025;20:e0333872.
    

    >> Share

    
    
27. ZHANG Y, Liu X, Zhang X, Fei Y, et al
    Machine learning-based prediction of metabolic dysfunction-associated steatotic liver disease using National Health and Nutrition Examination Survey (NHANES) data.
    PLoS One. 2025;20:e0335656.
    

    >> Share

    
    
28. QIAN W, Xu K, Li S, Zhang Z, et al
    Safety of penicillamine and trientine in the treatment of Wilson's disease: An analysis of the FDA Adverse Event Reporting System (FAERS) database.
    PLoS One. 2025;20:e0336721.
    

    >> Share

    
    
29. LIU Y, Zhang R, Sun X, Cui W, et al
    Transcriptomic and experimental evidence confirm the potential of disulfidptosis-related signature for the early diagnosis and treatment of liver cirrhosis.
    PLoS One. 2025;20:e0334459.
    

    >> Share

    
    
30. LIANG H, Song K
    Multi-omics analysis reveals metabolic regulation of phosphatidylcholine, triglycerides, phosphatidylethanolamine, and cardiolipin metabolism in mouse liver with metabolic dysfunction-associated steatotic liver disease.
    PLoS One. 2025;20:e0332177.
    

    >> Share

    
    
31. ZHANG J, Li W, Qiu X, Wang Y, et al
    Exploration of key markers driving ferroptosis in the progression of non-alcoholic fatty liver disease.
    PLoS One. 2025;20:e0320399.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

32. ALDOBIYAN I, Elliston ELK, Heyer-Chauhan N, Arold ST, et al
    The mechanism of pathogenic alpha(1)-antitrypsin aggregation in the human liver.
    Proc Natl Acad Sci U S A. 2025;122:e2507535122.
    

    >> Share

    
    

    
    Radiologia (Engl Ed)

33. GONZALEZ-HUETE A, Ventura-Diaz S, Olavarria Delgado A, Romera Sanchez R, et al
    Electromagnetic navigation system for CT-guided percutaneous abdominal tumour ablation: Safety and effectiveness.
    Radiologia (Engl Ed). 2025;67:101633.
    

    >> Share

    
    
34. BERBEL RODRIGUEZ A, Garcia-Baizan A, Frade-Santos S, Robles Gomez A, et al
    Mucin-producing cystic hepatobiliary neoplasms: Key diagnostic information for radiologists.
    Radiologia (Engl Ed). 2025;67:101568.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share